These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6791559)

  • 21. The emergence of bacterial resistance and its influence on empiric therapy.
    Neu HC
    Rev Infect Dis; 1983; 5 Suppl 1():S9-20. PubMed ID: 6342103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of infections, aetiological agents and antimicrobial resistance at a tertiary care hospital in northern Tanzania.
    Kumburu HH; Sonda T; Mmbaga BT; Alifrangis M; Lund O; Kibiki G; Aarestrup FM
    Trop Med Int Health; 2017 Apr; 22(4):454-464. PubMed ID: 28072493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance in Pseudomonas aeruginosa from infections of the ear, nose and throat.
    Rees TA
    Pract Otorhinolaryngol (Basel); 1971; 33(6):388-93. PubMed ID: 4337074
    [No Abstract]   [Full Text] [Related]  

  • 24. Choosing antimicrobials. Factors to consider, available agents.
    Pankey GA; Valainis GT
    Postgrad Med; 1985 May; 77(6):137-46. PubMed ID: 3846282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nationwide surveillance of 6 otorhinolaryngological infectious diseases and antimicrobial susceptibility pattern in the isolated pathogens in Japan.
    Suzuki K; Kurono Y; Ikeda K; Watanabe A; Iwamoto A; Totsuka K; Kaku M; Iwata S; Kadota J; Hanaki H
    J Infect Chemother; 2015 Jul; 21(7):483-91. PubMed ID: 26004175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.
    Neu HC
    Am J Med; 1984 Jul; 77(1B):11-23. PubMed ID: 6087659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems and dilemmas of antimicrobial resistance.
    Murray BE
    Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
    Mathai D; Lewis MT; Kugler KC; Pfaller MA; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aminoglycosides.
    Ristuccia AM; Cunha BA
    Med Clin North Am; 1982 Jan; 66(1):303-12. PubMed ID: 7038338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.
    Brook I
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():63-72. PubMed ID: 2691486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment.
    Smith A; Buchinsky FJ; Post JC
    Otolaryngol Head Neck Surg; 2011 Mar; 144(3):338-47. PubMed ID: 21493193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good antimicrobial prescribing. Aminoglycosides.
    Phillips I
    Lancet; 1982 Aug; 2(8293):311-4. PubMed ID: 6124725
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics--part 4: aminoglycosides.
    Barza M; Scheife RT
    Am J Hosp Pharm; 1977 Jul; 34(7):723-37. PubMed ID: 407790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory evaluation of the effect of cephradine on patients with ear, nose and throat infections.
    Malmborg AS; Meder B; Wersäll J
    Chemotherapy; 1975; 21(5):311-7. PubMed ID: 1157576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
    Niki Y; Aoki N; Suzuki K; Matsumoto T
    Jpn J Antibiot; 2009 Jun; 62(3):179-93. PubMed ID: 19882979
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmacology of aminoglycosides: II. Distinctions among the agents.
    Geller RJ; Norris SM
    Infect Control; 1984 Jun; 5(6):298-302. PubMed ID: 6376401
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose, and throat.
    Barza M
    Rev Infect Dis; 1988; 10 Suppl 1():S241-7. PubMed ID: 3279497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for the emergence of antibiotic resistance.
    Tenover FC; McGowan JE
    Am J Med Sci; 1996 Jan; 311(1):9-16. PubMed ID: 8571988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.